- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02719353
A Dispensing Clinical Trial of Comfilcon A Extended Range Multifocal Lenses
July 20, 2020 updated by: Coopervision, Inc.
The aim of this study is to validate the clinical of comfilcon A extended range high add center near (CN) multifocal lenses in existing contact lens wearers against the current comfilcon A high add multifocal lenses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is a 13-subject, randomized, prospective, single site, daily wear, single-masked (to the subject), bilateral, 4-day cross-over, dispensing study comparing the comfilcon A extended range multifocal test lens against the comfilcon A multifocal control lens.
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Bloomington, Indiana, United States, 47405
- CORL, Indiana University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
A person is eligible for inclusion in the study if he/she:
- Has had a self-reported oculo-visual examination in the last two years
- Is 50 years of age or greater and has full legal capacity to volunteer
- Is able to read and understand the informed consent
- Is willing and able to follow instructions and maintain the appointment schedule
- Has a spherical distance contact lens prescription between -1.00 and -5.00D (Diopters) (inclusive)
- Near Add Power requirement of +2.25D or greater
- Has spectacle cylinder 0.75 D in both eyes
- Has normal binocularity (no amblyopia, no strabismus, no habitually uncorrected anisometropia ≥ 2.00D)
- Has monocular best-corrected distance visual acuity of 20/30 or better in each eye
- Has clear corneas and no active ocular disease
- Has not worn gas permeable contact lenses for 1 month prior to the study
Exclusion Criteria:
A person will be excluded from the study if he/she:
- Has never worn contact lenses before
- Has any systemic disease affecting ocular health
- Is using any systemic or topical medications that will affect ocular health
- Has any ocular pathology or abnormality that would affect the wearing of contact lenses
- Is aphakic (i.e. missing their natural lens inside their eye)
- Has uncorrected anisometropia (i.e. difference in the prescription between the eyes) of ≥2.00 D
- Has undergone corneal refractive surgery
- Is participating in any other type of eye related clinical or research study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: comfilcon A Extended Range test lens
Subjects will be randomized to wear either the test or control pair of lens, then cross over to the alternate pair.
|
contact lens
contact lens
|
Active Comparator: comfilcon A control lens
Subjects will be randomized to wear either the test or control pair of lens, then cross over to the alternate pair.
|
contact lens
contact lens
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Acuity
Time Frame: 4 days
|
Visual acuity was measured at distance, intermediate and near conditions for test and control lens was assessed by LogMAR.
|
4 days
|
Visual Performance
Time Frame: 4 days
|
Subjective assessment of visual performance for test and control lens is assessed on a scale 0-100, 0=extremely poor vision all of the time and cannot function, 100= excellent vision all of the time).
|
4 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subjective Preference for Comfort
Time Frame: 4 days
|
Subjective preference for comfort for test and control contact lenses.
|
4 days
|
Subjective Preference for Intermediate Vision
Time Frame: 4 days
|
Subjective preference for intermediate vision for test and control contact lenses.
|
4 days
|
Subjective Preference for Distance Vision
Time Frame: 4 days
|
Subjective preference for distance vision for test and control contact lenses.
|
4 days
|
Average Daily Wearing Time
Time Frame: 4 days
|
Average daily wearing time for test and control lens is assessed in hours.
|
4 days
|
Subjective Ratings for Comfort
Time Frame: Baseline
|
Subjective ratings for comfort was assessed for test and control lens on a Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever).
|
Baseline
|
Subjective Ratings for Comfort
Time Frame: 4 days
|
Subjective ratings for comfort was assessed for test and control lens on a Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever).
|
4 days
|
Subjective Ratings for Dryness
Time Frame: Baseline
|
Subjective ratings for dryness was assessed for test and control lens on a scale 0-100, 0=cannot be worn, extremely dry, 100=no dryness experienced at any time).
|
Baseline
|
Subjective Ratings for Dryness
Time Frame: 4 days
|
Subjective ratings for dryness was assessed for test and control lens on a scale 0-100, 0=cannot be worn, extremely dry, 100=no dryness experienced at any time).
|
4 days
|
Lens Handling
Time Frame: 4 Days
|
Subjective ratings for handling (ease of insertion and removal) was assessed for test and control lens on a scale 0-100, 0=very difficult to handle, 100=easy to handle).
|
4 Days
|
Lens Fit
Time Frame: 4 days
|
Lens fit acceptance (general fit characteristics) is assessed for test and control lens on a 0-4 grading system in 0.25 steps where 0 represented very poor fit.
|
4 days
|
Bulbar Hyperemia
Time Frame: 4 days
|
Bulbar hyperemia was assessed on a scale of 0-4 and was used in 0.50 steps, with 0 indicating no hyperemia and 4 indicating severe hyperemia.
|
4 days
|
Limbal Hyperemia
Time Frame: 4 days
|
Limbal hyperemia was assessed on a scale of 0-4 and was used in 0.50 steps, with 0 indicating no hyperemia and 4 indicating severe hyperemia.
|
4 days
|
Subjective Satisfaction
Time Frame: 4 days
|
Subjective satisfaction for test and control lens was assessed on a scale 0-100, 0=extremely dissatisfied, 100=very satisfied)
|
4 days
|
Subjective Preference for Near Vision
Time Frame: 4 days
|
Subjective preference for near vision for test and control contact lenses.
comfort, vision, handling, satisfaction.
|
4 days
|
Subjective Preference for Overall Vision
Time Frame: 4 days
|
Subjective preference for overall vision for test and control contact lenses.
|
4 days
|
Subjective Overall Lens Preference
Time Frame: 4 days
|
Subjective overall lens preference for test and control contact lenses.
|
4 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Pete S Kollbaum, O.D., Indiana University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2016
Primary Completion (Actual)
May 1, 2016
Study Completion (Actual)
August 1, 2016
Study Registration Dates
First Submitted
March 21, 2016
First Submitted That Met QC Criteria
March 21, 2016
First Posted (Estimate)
March 25, 2016
Study Record Updates
Last Update Posted (Actual)
July 30, 2020
Last Update Submitted That Met QC Criteria
July 20, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CV-16-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presbyopia
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Technolas Perfect Vision GmbHUnknownHyperopic PresbyopiaIreland
-
Lee, Steven, M.D.CompletedMyopia, | Hyperopia, | Astigmatism, | Presbyopia, | Eye Strain,
-
Allotex, Inc.RecruitingPresbyopiaCzechia, Ireland, Turkey, United Kingdom
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.LENZ Therapeutics, IncRecruiting
-
Coopervision, Inc.Centre for Ocular Research & Education, CanadaRecruitingPresbyopiaUnited States, Canada
-
Optall VisionRecruiting
-
Allotex, Inc.TerminatedPresbyopiaBelgium, Ireland, United Kingdom
-
Coopervision, Inc.CORECompletedPresbyopiaUnited States, Canada
Clinical Trials on comfilcon A Extended Range test lens
-
Coopervision, Inc.CompletedPresbyopiaUnited States
-
Coopervision, Inc.Completed
-
Coopervision, Inc.Centre for Ocular Research & Education, CanadaRecruitingPresbyopiaUnited States, Canada
-
Coopervision, Inc.Completed
-
Coopervision, Inc.CompletedAstigmatism | MyopiaUnited Kingdom
-
Coopervision, Inc.Completed
-
Coopervision, Inc.Completed
-
Coopervision, Inc.Completed
-
Coopervision, Inc.Completed